Merck (MRK) will next year seek FDA approval for a pill for ragweed allergies following a...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

Merck (MRK) will next year seek FDA approval for a pill for ragweed allergies following a positive Phase III trial. The firm will also apply for authorization of a pill for grass allergies, with both treatments designed to obviate the need for injections. Merck is developing the immunotherapies with Danish drugmaker ALK-Abello (AKBLF.PK).